241 related articles for article (PubMed ID: 22828962)
1. Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma.
Feng Q; Wei H; Morihara J; Stern J; Yu M; Kiviat N; Hellstrom I; Hellstrom KE
Gynecol Oncol; 2012 Nov; 127(2):412-9. PubMed ID: 22828962
[TBL] [Abstract][Full Text] [Related]
2. Indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase expression in HPV infection, SILs, and cervical cancer.
Venancio PA; Consolaro MEL; Derchain SF; Boccardo E; Villa LL; Maria-Engler SS; Campa A; Discacciati MG
Cancer Cytopathol; 2019 Sep; 127(9):586-597. PubMed ID: 31412167
[TBL] [Abstract][Full Text] [Related]
3. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions.
Bais AG; Beckmann I; Lindemans J; Ewing PC; Meijer CJ; Snijders PJ; Helmerhorst TJ
J Clin Pathol; 2005 Oct; 58(10):1096-100. PubMed ID: 16189158
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.
Yang W; Song Y; Lu YL; Sun JZ; Wang HW
Immunology; 2013 Aug; 139(4):513-22. PubMed ID: 23521696
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.
Hu T; Yang P; Zhu H; Chen X; Xie X; Yang M; Liu S; Wang H
Diagn Pathol; 2015 Apr; 10():20. PubMed ID: 25885042
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
Aleksioska-Papestiev I; Chibisheva V; Micevska M; Dimitrov G
Med Arch; 2018 Feb; 72(1):26-30. PubMed ID: 29416214
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix.
Monnier-Benoit S; Mauny F; Riethmuller D; Guerrini JS; Căpîlna M; Félix S; Seillès E; Mougin C; Prétet JL
Gynecol Oncol; 2006 Jul; 102(1):22-31. PubMed ID: 16427684
[TBL] [Abstract][Full Text] [Related]
8. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Liu H; Liu S; Wang H; Xie X; Chen X; Zhang X; Zhang Y
Diagn Pathol; 2012 Oct; 7():147. PubMed ID: 23107094
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort.
Syrjänen S; Naud P; Sarian L; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Costa S; Syrjänen K
Virchows Arch; 2009 Dec; 455(6):505-15. PubMed ID: 19908064
[TBL] [Abstract][Full Text] [Related]
10. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
[TBL] [Abstract][Full Text] [Related]
11. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.
Guan P; Howell-Jones R; Li N; Bruni L; de Sanjosé S; Franceschi S; Clifford GM
Int J Cancer; 2012 Nov; 131(10):2349-59. PubMed ID: 22323075
[TBL] [Abstract][Full Text] [Related]
13. T-cell response to human papillomavirus type 58 L1, E6, And E7 peptides in women with cleared infection, cervical intraepithelial neoplasia, or invasive cancer.
Chan PK; Liu SJ; Cheung TH; Yeo W; Ngai SM; Cheung JL; Chong P; Man S
Clin Vaccine Immunol; 2010 Sep; 17(9):1315-21. PubMed ID: 20668141
[TBL] [Abstract][Full Text] [Related]
14. Targeted, Deep Sequencing Reveals Full Methylation Profiles of Multiple HPV Types and Potential Biomarkers for Cervical Cancer Progression.
Liu P; Iden M; Fye S; Huang YW; Hopp E; Chu C; Lu Y; Rader JS
Cancer Epidemiol Biomarkers Prev; 2017 Apr; 26(4):642-650. PubMed ID: 28069683
[No Abstract] [Full Text] [Related]
15. Effects of Th17 cells and IL-17 in the progression of cervical carcinogenesis with high-risk human papillomavirus infection.
Xue J; Wang Y; Chen C; Zhu X; Zhu H; Hu Y
Cancer Med; 2018 Feb; 7(2):297-306. PubMed ID: 29277958
[TBL] [Abstract][Full Text] [Related]
16. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
[TBL] [Abstract][Full Text] [Related]
18. Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia.
Iwata T; Fujii T; Morii K; Saito M; Sugiyama J; Nishio H; Morisada T; Tanaka K; Yaguchi T; Kawakami Y; Aoki D
Int J Clin Oncol; 2015 Feb; 20(1):126-33. PubMed ID: 24578180
[TBL] [Abstract][Full Text] [Related]
19. Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation.
Mesher D; Cuschieri K; Hibbitts S; Jamison J; Sargent A; Pollock KG; Powell N; Wilson R; McCall F; Fiander A; Soldan K
J Clin Pathol; 2015 Feb; 68(2):135-40. PubMed ID: 25410654
[TBL] [Abstract][Full Text] [Related]
20. Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions.
Azar KK; Tani M; Yasuda H; Sakai A; Inoue M; Sasagawa T
Hum Pathol; 2004 Nov; 35(11):1376-84. PubMed ID: 15668895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
